News About: Pharm. Affairs
iNtRON Biotechnology acquire U.S. FDA’s Orphan Drug Designation for Endolysin
iNtRON Biotechnology(CEO Kyung-Won Yoon), a new biologic developing company, announced on the 26th that its currently-developing bacillus anthracis based on endolysin called ‘N-Rephasin BAL200(hereinafter referring to...
A number of 24/7 convenient stores do not sell emergency household medicines at night
According to the research result on the emergency household medicines sold at 24/7 convenient stores, there a number of convenient stores which do not manage these sales well at night.
Korea Institute for Pharmaceuti...
JW Pharmaceutical receives official safety certification of ‘Livalo’ in treating diabetes in 10 countries
Hyperlipidemia treatment ‘Livalo(generic name: pitavastatin)’ was once officially certified that it has no symptoms causing diabetes from another country.
JW Pharmaceutical(CEO Jae-Kwang Jeon & Young-Sup Shin) announ...
“They must stop selling Tylenol with hepatotoxic and asthma risks at convenient stores”
A petition was filed to suspend sales of Tylenol 500mg and Tylenol Syrup at convenient stores.
At the Blue House National Petition on the 14th, a petition was registered under a title called “Please immediately stop ...
Revised medical guidance for dyslipidemia, what would be like?
The Korean Society of Lipid and Atherosclerosis gave a notice of announcement of a revision to the ‘Medical Guidance for Dyslipidemia,’ which attracts the industry over how it would be changed.
The medical guidance ...
Kolon Life Science’s osteoarthritis therapy ‘Invossa K’ landed in 60 general hospitals
‘Invossa,’ a gene therapy for osteoarthritis, will start to be prescribed in general hospitals.
Kolon Life Science(CEO Woo-Seok Lee) and Mundipharma(CEO Myung-Sae Lee) announced on the 11th that the world’s first and...
274 products approved after 2010, 1 of 5 were ‘anticancer drugs’
1 of 5 new drugs approved in Korea after 2010 were reportedly was anticancer drugs.
The Ministry of Food and Drug Safety(MFDS) said 274 products were approved as new drugs in Korea between 2010 and the last year.
Th...
‘Lipiodol’ takes drug price negotiation after being designated as shortage-prevented drug
‘Lipiodol’ which has recently caused controversy with its supply suspension will get on a drug price negotiation after being designated as a shortage-prevented drug.
‘Erbitux’ which ended the drug price negotiation w...
Olympics for biochemists will be held on 7 June in Seoul
2018 International Union of Biochemistry and Molecular Biology(IUBMB) Congress, also known as Olympics for biochemists, will be held at Seoul COEX on 7 June.
For this event held first time in Seoul, about 5,000 scien...
Total 1,603 products selected for differential application of small-packaging supply
Total 1,603 products were selected as products that would be differentially applied under the drug small-packaging standards for this year.
The Ministry of Food and Drug Safety(MFDS) notified the products for the dif...
